Cannabis Laws Across Asia and Key Global Markets — Mid-2026 Comprehensive Update

GOOD_BUDS · 7월 24, 2026, 6:46오전

Cannabis Laws Across Asia and Key Global Markets — 2026 Update

A comprehensive guide to the current legal status of cannabis, CBD, and hemp across the Asian region and connected global markets. Last updated: July 2026.

Thailand

Status: Medical only (controlled herb)

Thailand made history as the first Asian country to legalize medical cannabis in 2018 and briefly decriminalized recreational use in 2022. However, the landscape shifted dramatically:

June 26, 2025: Cannabis reclassified as a controlled herb under the Notification on Controlled Herbs (Cannabis) B.E. 2568
April 2026: Ministerial Regulation B.E. 2569 introduced licensing and permit requirements
Cannabis flower requires a PT33 prescription from a licensed practitioner
Extracts with <0.2% THC remain unrestricted
Recreational use is prohibited — penalties up to 1 year imprisonment and 20,000 THB fine
Online sales of cannabis are prohibited
Of 18,433 cannabis shops operating before the new regulations, 7,297 have shut down as of February 2026

CBD/Hemp: Legal. Hemp-derived products with <0.2% THC are freely available.

Indonesia

Status: Strict prohibition — severe penalties

Cannabis is a Group I narcotic under Law 35 of 2009, the most severe category alongside heroin
Indonesian law does not recognize the THC/CBD distinction — all cannabis derivatives including CBD and hemp are illegal
Personal-use possession: 4–12 years imprisonment + fines of 800 million to 8 billion IDR (~$50K–$500K)
Cultivation and supply: 5 years to life imprisonment
Trafficking: Can attract the death penalty
The BNN (National Narcotics Agency) announced medical cannabis research in May 2025, but no policy changes have been implemented
The new 2026 Criminal Code (KUHP) did not decriminalize cannabis — narcotics penalties remain intact
Warning for travelers: Medical marijuana from home countries, including CBD, will be confiscated and treated as evidence of drug trafficking

Japan

Status: Strict prohibition with limited medical reform

Japan maintains some of the world’s strictest cannabis laws under the Cannabis Control Act, but a historic shift occurred in late 2024:

December 2024: Japan amended the Cannabis Control Act to allow pharmaceutical-grade cannabis-derived medicines (specifically Epidiolex for epilepsy treatment)
This marks the first legal medical cannabis use in Japan’s modern history
Recreational use, possession, and cultivation remain strictly illegal — penalties include up to 7 years imprisonment
CBD: Legal, provided it contains 0% THC (zero tolerance). CBD products are widely available in major cities
Japan has a growing CBD market estimated at over $200 million

South Korea

Status: Limited medical use

South Korea became the first East Asian country to legalize medical cannabis in 2018:

The Ministry of Food and Drug Safety (MFDS) approves cannabis-based medicines on a case-by-case basis
Approved medications include Epidiolex, Marinol, and Sativex
Patients must apply through MFDS — no domestic cultivation or dispensary system exists
Recreational use remains strictly illegal — penalties include up to 5 years imprisonment
CBD: Legal only in pharmaceutical products approved by MFDS

India

Status: Complex — varies by state

India’s relationship with cannabis is uniquely complex, blending ancient tradition with modern drug policy:

Federal level: Cannabis is controlled under the Narcotic Drugs and Psychotropic Substances Act (NDPS) 1985
However, bhang (cannabis leaf preparation) is explicitly excluded from the NDPS Act definition
Several states have varying degrees of tolerance — Uttarakhand was the first state to legalize hemp cultivation in 2018
Hemp: Increasingly recognized. Multiple states (Uttarakhand, Uttar Pradesh, Madhya Pradesh, Manipur, Himachal Pradesh) have approved hemp cultivation with THC limits of 0.3%
CBD: Legal gray area — no specific regulation, but hemp-derived CBD products are available
The Ayurvedic and traditional medicine framework provides legal pathways for cannabis-based medicines

Israel

Status: Comprehensive medical program — largest per capita in the world

Israel has been a global pioneer in cannabis research since the 1960s (Prof. Raphael Mechoulam isolated THC in 1964):

~130,000 licensed medical cannabis patients — one of the highest per-capita rates globally
The Israel Medical Cannabis Agency (IMCA) oversees the program
Major importer: 302,268 imported flower packages reported in 2025, primarily from Canada
Export: Israel exports medical cannabis to Germany, UK, Australia, and other regulated markets
A proposed 165% tariff on Canadian imports is reshaping trade flows in 2026
Israel’s Health Ministry has recommended phasing out smoked medical cannabis over three years
Recreational: Decriminalized for personal use since 2017 (fines, no criminal record for first offenses)

Nepal

Status: Prohibited federally — provincial reform underway

Nepal has a long historical relationship with cannabis, but modern law remains strict:

Narcotic Drugs (Control) Act 1976: Prohibits cultivation, production, and sale of cannabis
2026 breakthrough: Gandaki Province became the first province to approve a medical and industrial marijuana cultivation bill
A second province is also pursuing similar legislation
Proposed THC threshold: <0.3% for industrial hemp
CBD/Hemp: No separate legal recognition yet — federal law still classifies all cannabis derivatives as controlled substances
The provincial bills still conflict with the federal Narcotic Drugs Act — resolution is pending

Malaysia

Status: Prohibited — severe penalties

Cannabis is classified as a dangerous drug under the Dangerous Drugs Act 1952
Possession of >200g can trigger a mandatory death penalty (though enforcement has been reformed in recent years)
In 2021, the government allowed import of medical cannabis-containing pharmaceutical products under strict conditions
CBD: Not explicitly legal — falls under dangerous drugs classification
Public discussion around medical cannabis has increased, but no legislative change as of 2026

China

Status: Strict prohibition — but world’s largest hemp producer

Cannabis is classified as a narcotic — recreational and medical use are strictly illegal
Penalties include detention and up to 15 years imprisonment
However, China is the world’s largest industrial hemp producer, primarily in Yunnan and Heilongjiang provinces
CBD: Prohibited for internal consumption; allowed in cosmetics in some provinces
China holds more cannabis-related patents than any other country
Hemp fiber and seed products are a major industry

Singapore

Status: Zero tolerance — among the strictest in the world

The Misuse of Drugs Act imposes severe penalties, including the death penalty for trafficking >500g of cannabis
Possession, consumption, and cultivation are all criminal offenses
In 2021, two patients received special permission for medical cannabis (epilepsy treatment) — no broader program exists
CBD: Illegal — classified as a controlled substance regardless of THC content
Singapore’s National Research Foundation is researching synthetic cannabinoids for Alzheimer’s and Parkinson’s

Cambodia

Status: Technically illegal — widely tolerated

Cannabis is listed as a controlled substance under the 1996 Law on Drug Control
Despite this, cannabis use is openly tolerated in many tourist areas and traditional communities
Cannabis has historically been used in Cambodian cooking (e.g., “happy pizza”)
No medical cannabis program exists
CBD: No specific regulation
Law enforcement focuses on trafficking, not personal use

Philippines

Status: Prohibited — medical cannabis bill advancing

Cannabis is illegal under the Comprehensive Dangerous Drugs Act (RA 9165)
Possession penalties: 12 years to life imprisonment + fines up to 10 million PHP
CBD: The FDA’s Compassionate Special Permit (CSP) allows importation of non-THC cannabis-derived pharmaceuticals (CBD oils) for specific debilitating conditions — extremely limited access
Hemp: Illegal — no distinction between hemp and marijuana
2026 development: The House Committee on Health unanimously approved the Philippine Compassionate Medical Cannabis Act (HB 180), proposing Medical Cannabis Compassionate Centers in DOH hospitals and the creation of a Medical Cannabis Office (MCO)
The bill is still pending full congressional and senate approval
If passed, the Philippines could become one of the largest medical cannabis markets in Southeast Asia

Laos

Status: Cannabis illegal — hemp cultivation approved

Cannabis remains illegal under the Law on Narcotics (2007) and the Penal Code (2017)
However, a 2022 Decision approved regulated hemp activities: cultivation, extraction, production, processing, storage, distribution, import-export
Companies must obtain approvals from the Ministry of Health and Ministry of Planning and Investment
The narcotics law and hemp decision currently conflict — harmonization is pending
CBD/Hemp: Hemp activities are permitted under the 2022 Decision, but the legal framework remains unclear
Recreational cannabis use is informally tolerated in some tourist areas but remains illegal

Myanmar

Status: Strict prohibition

Cannabis is illegal for both recreational and medical use under the 1993 Narcotic Drugs Law
Cultivation: 5–10 years imprisonment + fines
Sale, transport, import/export: Minimum 15 years imprisonment
No medical cannabis program exists
Chinese companies have explored growing non-intoxicating cannabis strains in Myanmar for industrial use, but this would require changes to drug law
CBD/Hemp: No legal framework

Hong Kong

Status: Zero tolerance — CBD banned since 2023

Cannabis is illegal under the Dangerous Drugs Ordinance (DDO)
February 1, 2023: CBD was reclassified as a dangerous drug — previously legal CBD products are now completely banned
Trafficking penalties: Up to life imprisonment and HK$5 million fine
Possession/consumption: Up to 7 years imprisonment and HK$1 million fine
No medical cannabis program
This represents one of the most dramatic tightenings in Asia — Hong Kong went from a thriving CBD market to complete prohibition overnight

Taiwan

Status: Strict prohibition — extremely limited CBD

Cannabis is a Category 2 narcotic under the Narcotics Hazard Prevention Act
Use: Up to 3 years imprisonment
Possession: Up to 2 years imprisonment
Trafficking: 7 years to life imprisonment
CBD: Legal only by doctor’s prescription with <0.001% THC (extremely strict threshold) — no approved domestic CBD products, import only
Hemp: Cultivation is illegal
No medical cannabis program

Sri Lanka

Status: Prohibited domestically — export cultivation licensed

Recreational and medical cannabis use remain illegal domestically
2025 breakthrough: Sri Lanka granted first-ever licenses for cannabis cultivation for export — 30 foreign investors now operate under strict export-only regulations
Minimum investment requirement: $5 million+
Zero tolerance for leakage into the domestic market
Overseen jointly by the Board of Investment, Ministry of Public Security, Ministry of Environment, and Department of Ayurveda
Cannabis has historical roots in Ayurvedic medicine — documented in ancient texts dating to 341 AD (King Buddadasa’s Sarartha Sangrahaya)

Pakistan

Status: Recreational illegal — industrial/medical framework emerging

Recreational cannabis is illegal under the Control of Narcotic Substances Act 1997
September 2020: The Federal Cabinet approved a framework for industrial hemp and medical cannabis cultivation
The Ministry of Science and Technology was designated as lead agency
Commercial implementation has been slow, but the policy direction is set
Cannabis (especially hashish) has deep cultural roots in parts of Pakistan, particularly in the northern regions
CBD/Hemp: Legal framework exists on paper but commercial activity remains limited

Germany (Key Connected Market)

Status: Legal for adults — Cannabis Social Clubs

Germany’s Cannabis Act (CanG) took effect April 1, 2024, making it the most significant legalization in Europe:

Adults 18+ can possess up to 25g in public, 50g at home
Home cultivation of up to 3 plants per person
Cannabis Social Clubs (Anbauvereinigungen): Non-profit clubs of up to 500 members that collectively cultivate cannabis
Over 500 clubs registered as of 2026
No commercial retail sales — clubs are the only legal access point besides home growing
Medical cannabis: Fully legal since 2017 through pharmacies with a prescription
Germany is the largest medical cannabis market in Europe — key import destination from Israel, Canada, Portugal, and increasingly Thailand

Czech Republic (Key Connected Market)

Status: Decriminalized — medical program established

Personal possession of up to 10g is decriminalized (administrative fine)
Home cultivation of up to 5 plants is decriminalized
Medical cannabis: Legal since 2013 through the State Agency for Medical Cannabis (SAKL)
Covered by health insurance since 2020 (up to 30g/month)
CBD products with <1% THC are legal and widely available
Czech Republic is actively developing its hemp industry

Summary Table

Country	Medical	Recreational	CBD	Hemp	Death Penalty Risk
Thailand	PT33 prescription	Prohibited	<0.2% THC	Licensed	No
Indonesia	No	Severe	No THC/CBD distinction	No	Trafficking
Japan	Pharma only (2024)	Strict	0% THC only	Limited	No
South Korea	Case-by-case	Strict	Pharma only	No	No
India	Traditional/State	Varies by state	Gray area	Several states	No
Israel	130K patients	Decriminalized	Yes	Yes	No
Nepal	Provincial reform	No	No	Reform pending	No
Malaysia	Import only	Severe	No	No	>200g
China	No	Strict	Cosmetics only	World’s largest	No
Singapore	No	Zero tolerance	No	No	>500g
Cambodia	No	Tolerated	No regulation	No regulation	No
Philippines	Bill advancing	Severe	CSP only	No	No
Laos	No	No	Hemp decision	2022 Decision	No
Myanmar	No	Strict	No	No	No
Hong Kong	No	Strict	Banned 2023	No	No
Taiwan	No	Strict	Rx only <0.001%	No	No
Sri Lanka	No	No	No	Export-only (2025)	No
Pakistan	Framework 2020	No	Limited	Framework 2020	No
Germany	Since 2017	Social Clubs (2024)	Yes	Yes	No
Czech Republic	Since 2013	Decriminalized	<1% THC	Yes	No

Key Trends in 2026

Medical expansion continues: Japan’s 2024 pharmaceutical reform, Nepal’s provincial bills, and the Philippines’ Compassionate Medical Cannabis Act signal growing acceptance across Asia
Regulatory tightening in Thailand: The 2025-2026 re-regulation demonstrates that liberalization isn’t always permanent — Thailand is now focused on a structured medical-only framework
CBD crackdown in some jurisdictions: Hong Kong’s 2023 ban on CBD (previously legal) shows that not all trends point toward liberalization
CBD as the gateway: CBD legalization often precedes broader cannabis reform — Japan’s $200M+ CBD market and India’s hemp industry are examples
Export-oriented models emerging: Sri Lanka’s export-only cultivation licenses ($5M+ investment) and Thailand’s GACP/GMP flower exports represent a new model — production for export while maintaining domestic prohibition or strict regulation
Import/Export corridors forming: Thailand to EU (GACP/GMP flowers), Israel and Canada (medical flowers), Sri Lanka to global (Ayurvedic export), Germany as key import destination
Death penalty remains: Malaysia, Singapore, Indonesia, and maintain extreme penalties for trafficking — professionals operating in these jurisdictions must exercise maximum caution
Divide between ASEAN nations: Thailand leads with medical framework, Philippines advancing legislation, Laos exploring hemp — while, Indonesia, Myanmar, and Singapore maintain strict prohibition

This article is for informational and educational purposes only. Cannabis laws change frequently — always verify current regulations with official government sources in your jurisdiction before taking any action. This forum does not provide legal advice.

Discuss these developments with fellow professionals in the comments below. What changes are you seeing in your market?

Sources:

Thailand: Notification on Controlled Herbs (Cannabis) B.E. 2568; Ministerial Regulation B.E. 2569
-: Cannigma Cannabis Laws 2026
Indonesia: Law 35 of 2009; KUHP 2026; Cannabis Regulations AI
Japan: Cannabis Control Act Amendment 2024
South Korea: Ministry of Food and Drug Safety (MFDS) Medical Cannabis Regulations
India: NDPS Act 1985; State hemp cultivation policies
Israel: Israel Medical Cannabis Agency (IMCA); GrowerIQ Market Report 2025
Nepal: Gandaki Province Medical & Industrial Marijuana Cultivation Bill 2026
Malaysia: Dangerous Drugs Act 1952
Philippines: RA 9165; House Bill 180 (Compassionate Medical Cannabis Act)
Laos: 2022 Decision on Hemp Activities; Tilleke & Gibbins analysis
Hong Kong: Dangerous Drugs Ordinance amendment 2023
Taiwan: Narcotics Hazard Prevention Act; Cannabis Regulations AI
Sri Lanka: Board of Investment export cultivation licenses 2025
Pakistan: Federal Cabinet framework 2020
Germany: Cannabis Act (CanG) 2024
Czech Republic: State Agency for Medical Cannabis (SAKL)
General: Cannigma Asia Cannabis Legal Map 2026; Cannabis Regulations AI; Cannatopia Farm

Read in: English | ไทย | Tiếng Việt | 中文 | Русский | 日本語 | 한국어 | हिन्दी | Deutsch